首页> 外国专利> MECHANISM-BASED TARGETED PANCREATIC beta-CELL IMAGING AND THERAPY

MECHANISM-BASED TARGETED PANCREATIC beta-CELL IMAGING AND THERAPY

机译:基于机制的靶向胰腺β细胞成像和治疗

摘要

PPROBLEM TO BE SOLVED: To provide a composition and a method for imaging -cells in vivo, and a composition and a method for improving diagnosis and treatment of pancreas-associated diseases based on finding the delivery of a pharmaceutical agent having therapeutic value specific to pancreatic -cells. PSOLUTION: The composition for imaging the -cells includes a chelating agent-antidiabetic agent conjugate and, if needed, a metal to be chelated. The composition for imaging the pancreas including the antidiabetic agent, the chelating agent and a metal ion to be chelated are disclosed. The method for treating the pancreas is also disclosed. The method includes a process for administering the composition including the antidiabetic agent, the chelating agent and the metal ion to be chelated to subjects requiring the treatment of pancreatic diseases. In the composition, the metal ion is a -ray emitter. PCOPYRIGHT: (C)2011,JPO&INPIT
机译:

要解决的问题:基于发现具有治疗价值的药剂的递送,提供用于体内成像细胞的组合物和方法以及用于改善胰腺相关疾病的诊断和治疗的组合物和方法。特定于胰腺细胞。

解决方案:用于使细胞成像的组合物包括螯合剂-抗糖尿病药结合物,以及如果需要的话,将被螯合的金属。公开了用于使胰腺成像的组合物,其包括抗糖尿病药,螯合剂和待螯合的金属离子。还公开了治疗胰腺的方法。该方法包括将包含抗糖尿病药,螯合剂和要被螯合的金属离子的组合物给予需要治疗胰腺疾病的受试者的方法。在组合物中,金属离子是射线发射器。

版权:(C)2011,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号